Innovative Asset Advisors Group »

Vaneck Vectors Pharmaceutical etf shares owned by Innovative Asset Advisors Group

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Innovative Asset Advisors Group from 13F filings

Historical chart of Innovative Asset Advisors Group investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Innovative Asset Advisors Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Innovative Asset Advisors Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $68k 654 103.88

More positions owned by Innovative Asset Advisors Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Cap Stk Cl C CL C (GOOG)
Broadcom (AVGO)
Spdr Gold Shares Etf (GLD)
Nebius Group N.v. Shs Class A Cl A (NBIS)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Alphabet Inc Cap Stk Cl A Cl A (GOOGL)
Raytheon Technologies Corp (RTX)
Palantir Technologies Inc Cl A Cl A (PLTR)
Berkshire Hathaway Inc Del Cl B CL B (BRK.B)
Vanguard S&p 500 Etf Etf (VOO)
Exxon Mobil Corporation (XOM)

View all positions for Innovative Asset Advisors Group

Top funds holding Vaneck Vectors Pharmaceutical etf

Healthcare Of Ontario Pension Plan Trust Fund
Goldman Sachs Group
Jane Street
Bnp Paribas Arbitrage, Snc
British Columbia Investment Management Corporation
Employees Retirement System of Texas
Wellington Management Company
Royal Bank of Canada
J.Safra Asset Management
Avalon Trust
Citigroup
Morgan Stanley
Adamsbrown Wealth Consultants
Bank of America Corporation
Miller Investment Management

View all funds holding Vaneck Vectors Pharmaceutical etf